Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Muscle protein Miro1 may drive insulin resistance, revealing potential type 2 diabetes treatment target (opens in a new tab)

medicalxpress.com · 2026-10-19

Short answerEvidenceSource

Short answer

Needs review

Study found.

We found the study, but the claim check did not finish.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

We found the study behind this story.

We found the study, but couldn't compare the story to it: the study's evidence could not be profiled.

Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

  • The study this story reportsmentioned without context

    Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes

    Nature Communications · 2026

    Publisher (opens in a new tab)
  • The study this story reportspresented as the new finding

    Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes

    Nature Communications · 2026

    Publisher (opens in a new tab)
Then inspect each claim

Evidence layer

Claim by claim

The source study was found, but the study's evidence could not be profiled, so these claims couldn't be checked.

Claim 1 of 5Not checkedA protein called Miro1, found at elevated levels in the skeletal muscle of people with type 2 diabetes, may contribute to insulin resistance and could be a target for future treatments.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 2 of 5Not checkedExercise reduced Miro1 levels in people with type 2 diabetes.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 3 of 5Not checkedResearchers found that removing Miro1 restored the muscles' response to insulin in preclinical models.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 4 of 5Not checkedThe exercise finding came from a randomized controlled trial involving people with obesity and type 2 diabetes, comparing aerobic exercise with standard medical care.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Claim 5 of 5Not checkedParticipants in the exercise group experienced reductions in muscle Miro1 levels, along with improvements in insulin sensitivity and the muscles' ability to produce energy.View evidenceHide evidence

Not checked

The source study was found, but this claim couldn't be checked against it.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Open the paper in Tessa

Miro1 mediates skeletal muscle insulin resistance in type 2 diabetes

Nature Communications · 2026

Source record (opens in a new tab)

Why this one

Near certain

NewsLink found the paper. Tessa is where you inspect it deeply.

Papers considered

The selected paper, plus nearby candidates.

Crossref, PubMed, Europe PMC · 15 candidate papers

Candidate

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus

Crossref

Source (opens in a new tab)
Candidate

Altered Cathepsin B Expression as a Diagnostic Marker of Skeletal Muscle Insulin Resistance in Type 2 Diabetes

Crossref

Source (opens in a new tab)

And 9 more candidates considered.